Skip to content

Clinical trials

Terminated Diabetes Mellitus trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Status: Terminated Country / region: China Clear all

10 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20072
20093
20111
20181
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated10

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Harbin Medical University2
Beijing Suncadia Pharmaceuticals Co., Ltd1
Chinese University of Hong Kong1
GlaxoSmithKline1
Johnson & Johnson Medical, China1
Novo Nordisk A/S1
RenJi Hospital1
Sun Yat-sen University1
Wyeth is now a wholly owned subsidiary of Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus10
Diabetes Mellitus, Type 23
Anemia1
Cardiovascular Diseases1
Coronary Artery Disease1
Coronary Disease1
Neuralgia1
Pain1
Renal Insufficiency, Chronic1

Trials

Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.